Broadwater Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.28M Sell
29,482
-100
-0.3% -$13.8K 3.04% 10
2026
Q2
$3.8M Sell
29,582
-250
-0.8% -$29.3K 2.76% 10
2026
Q1
$3.14M Hold
29,832
– – 2.35% 11
2025
Q4
$3.14M Hold
29,832
– – 2.35% 11
2025
Q3
$2.5M Hold
29,832
– – 1.83% 16
2025
Q2
$2.36M Sell
29,832
-150
-0.5% -$11.9K 1.84% 18
2025
Q1
$2.69M Hold
29,982
– – 2.11% 13
2024
Q4
$2.98M Hold
29,982
– – 2.29% 12
2024
Q3
$3.4M Sell
29,982
-250
-0.8% -$29.7K 2.51% 10
2024
Q2
$3.74M Hold
30,232
– – 2.89% 8
2024
Q1
$3.99M Sell
30,232
-800
-3% -$98.6K 3.06% 7
2023
Q4
$3.38M Buy
+31,032
New +$3.22M 2.65% 8

Other funds holding MRK

Broadwater Capital's MRK Position: Q3 2026 in Review

Broadwater Capital reduced its Merck (MRK) stake by 0.34% in Q3 2026, selling an estimated $13.8K and leaving 29,482 shares worth $4.28M. The position accounts for 3.04% of the portfolio, ranked #10.

Broadwater Capital first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 3,961 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Broadwater Capital held 29,482 shares of Merck worth $4.28M as of Q3 2026.
  • Broadwater Capital sold 100 Merck shares in Q3 2026, an estimated $13.8K.
  • Merck made up 3.04% of Broadwater Capital's portfolio in Q3 2026, its #10 holding.
  • Broadwater Capital first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • 3,961 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Broadwater Capital's 13F filing for Q3 2026, filed 12 Nov 2026.